Bennett’s experience spans healthcare product categories, care settings, and end markets, including medical devices / technology, pharmaceuticals, biologics, acute care, and home care. He has been responsible for growth in both U.S. and international markets.
“Josh brings knowledge, experience and industry contacts to KORU Medical at a time of expanding opportunity,” said Pettigrew. “He has a broad and proven record of building marketing programs and creating new sales channels domestically and internationally that deliver strong results. We believe that Josh’s skills align well with our goals of identifying new and adjacent market opportunities, expanding the therapeutic and pharmaceutical applications of our Freedom60 integrated infusion system, and leveraging what we view as significant advantages of self-administered at-home infusion therapy.”
He joins KORU Medical from Salter Labs, a global anesthesia and respiratory medical device manufacturer, where he served as vice president Sales, Marketing, and Business Development beginning in 2012. Salter Labs merged with SunMed in 2019. Prior to this, he was with Baxter Healthcare, a Fortune 500 diversified global pharmaceutical and device manufacturer. At Baxter he focused on pharmaceuticals and biologics, with an emphasis on product and market development addressing nutrition, hydration, and hemophilia. Bennett began his career at PwC Consulting (now IBM Global Business Services).
Bennett earned his MBA from the Kellogg School of Management at Northwestern University, where he was a Siebel Scholar and recipient of the Richard M. Clewett Award, and his BBA from Northwood University.
“I am excited to join KORU Medical at a time of significant growth and market capture potential,” said Bennett. “I look forward to collaborating with the team to expand KORU Medical’s patient-focused platform and advance the company’s long-term growth strategy.”